Reimold, P.; Tosev, G.; Kaczorowski, A.; Friedhoff, J.; Schwab, C.; Schütz, V.; Görtz, M.; Panzer, N.; Heller, M.; Aksoy, C.;
et al. PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study. Diagnostics 2024, 14, 741.
https://doi.org/10.3390/diagnostics14070741
AMA Style
Reimold P, Tosev G, Kaczorowski A, Friedhoff J, Schwab C, Schütz V, Görtz M, Panzer N, Heller M, Aksoy C,
et al. PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study. Diagnostics. 2024; 14(7):741.
https://doi.org/10.3390/diagnostics14070741
Chicago/Turabian Style
Reimold, Philipp, Georgi Tosev, Adam Kaczorowski, Jana Friedhoff, Constantin Schwab, Viktoria Schütz, Magdalena Görtz, Niklas Panzer, Martina Heller, Cem Aksoy,
and et al. 2024. "PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study" Diagnostics 14, no. 7: 741.
https://doi.org/10.3390/diagnostics14070741
APA Style
Reimold, P., Tosev, G., Kaczorowski, A., Friedhoff, J., Schwab, C., Schütz, V., Görtz, M., Panzer, N., Heller, M., Aksoy, C., Himmelsbach, R., Walle, T., Zschäbitz, S., Jäger, D., Duensing, A., Stenzinger, A., Hohenfellner, M., & Duensing, S.
(2024). PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study. Diagnostics, 14(7), 741.
https://doi.org/10.3390/diagnostics14070741
